Virtually every day, Americans can open a newspaper or turn on the news channel to view accounts of America's growing substance abuse problem. No longer primarily isolated to larger cities, many cases are also now reported in local suburban or rural communities. This could be happening due to the emergence of a newer class of psychoactive drugs in the past decade which the internet made fairly available (Mycyk, 2012). They are sometimes known as designer drugs, but are more commonly called synthetic drugs. Though there are several different classes of these substances, one form in particular has become attractive for people motivated to avoid drug detection, such as adolescents wanting to experiment, military personnel, or people working in occupations associated with mandatory drug testing (Linday, 2012). This substance is formally called synthetic cannabinoid, or synthetic marijuana, but is commonly coined "spice" or "K2" (McGuinness, F.A.A.N., & Newell, 2012). Like most drugs, there are many dangers associated with its use. Therefore, the regulation issue inevitably comes into play. Is the Food and Drug Administration Safety and Innovation Act (2012), recently passed and containing provisions under Section 1152 to Federally ban synthetic cannabinoid agents, an adequate measure in itself to control the sale and use of spice? Should additional laws be established by the individual States that contain more specific verbiage? Or is it possible that users only seek an undetectable, freely-available "synthetic high" because non-synthetic marijuana is not Federally legal nor lawful within their home State? Though the toxicity of spice is not yet fully known, it's dangerous and sometimes deadly symptoms seem to indicate that American lawmakers, on both State and Federal levels, should be urgent in their efforts to effectively control it. The risks associated with the substance are not merely presumed. The American Association of Poison Control Centers reported that toxic reactions to synthetic cannabinoids has drastically increased. In 2010, the Centers received approximately 2,900 calls reporting adverse effects from spice; while 7,000 calls were received in 2011 (Hoyte, 2012). In a study of 869 college students, (Hu, 2011) found that approximately 1 in 10 students admitted ever having tried synthetic cannabinoids, with higher rates of use among males. Presenting symptoms of spice users have included, but are not limited to, heart attacks, seizures, and hallucinations (Griep, 2013). Particularly illustrative of the harmful effects of this substance is the story of a Texas teenager, Emily Bauer. Christina Zdanowicz (2013) describes Emily's horrifying tale on CNN Health. Sixteen at the time of the incident, Emily was an A and B sophomore in school who reportedly began her experience with spice by smoking it every day for two weeks straight. Her parents attest that on December 8, 2012, Emily was admitted the ICU of a Houston area hospital. Apparently the previous afternoon she had smoked spice with several of her peers. Afterwards she complained of another of the many migraines which had recently plagued her, and took a nap to ward off the persisting pain. She awoke in a state of violent disturbance, suffering from hallucinations. At the hospital, Emily attempted to bite the bed guardrail as well as the individuals trying to assist her. Given the degree of physical force she displayed, health professionals placed her in a medically induced coma to avoid further harm to herself o